Diet and Lifestyle Factors Associated with Premenstrual Symptoms in a Racially Diverse Community Sample: Study of Women's Health Across the Nation (SWAN)

Gold, Ellen B.; Bair, Yali A.; Block, Gladys; Greendale, Gail A.; Harlow, Sioḃán D.; Johnson, Susan R.; Kravitz, Howard M.; Rasor, Marianne O'Neill; Siddiqui, Amna Rehana; Sternfeld, Barbara; Utts, Jessica; Zhang, Guili

doi:10.1089/jwh.2006.0202

Cited by 69 publications

(71 citation statements)

References 56 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…An elevated hs-CRP level was not associated with reporting premenstrual breast pain or headaches in unadjusted analyses. Other factors related to each symptom group were similar to those we found previously 12 (data not shown). We also examined the unadjusted mean hs-CRP by number of symptom groups reported and found a trend of increasing means (from 3.11 -7.78 mg/L for none, 3.18 -9.12 mg/L for one, 3.06 -4.76 for two, 3.51 -5.31 mg/L for three, 4.25 -6.52 mg/L for four to 4.22 -5.38 mg/L for five symptoms) with increasing number of symptom groups, which was significant in ANOVA ( p = 0.026), but the trend was not monotonic.…”

Section: Unadjusted Analysessupporting

confidence: 87%

“…Factors were accepted with an eigen value of 1.0 or greater. As in our prior work, 12 the five resulting PMSx groupings were as follows: (1) anxiety/ jittery/nervous and mood changes, (2) abdominal cramps and back/joint/muscle pain, (3) increased appetite/craving and weight gain/bloating, (4) breast pain/tenderness, and (5) headaches. Because women often reported more than one symptom, associations of the independent variables with the total number of these five symptom groupings (>3 vs. £3) were also estimated.…”

Section: Data Analysesmentioning

confidence: 99%

“…Biologic, social, demographic, and behavioral factors have been inconsistently associated with PMSx. 2,[9][10][11][12] High-sensitivity C-reactive protein (hs-CRP) is an acute phase inflammatory marker that has been associated with cardiovascular disease risk 13 and is an outcome associated with menopausal vasomotor symptoms. 14 It has also been associated with some of the risk factors for PMSx, such as smoking, depressive symptoms, increasing age, and increased body mass index (BMI).…”

mentioning

confidence: 99%

See 2 more Smart Citations

The Association of Inflammation with Premenstrual Symptoms

Gold

Wells

Rasor

2016

Journal of Women's Health

Self Cite

View full text Add to dashboard Cite

Background: About 80% of women experience premenstrual symptoms (PMSx), and about 50% of women seek medical care for them, posing a large medical care burden. However, despite women's use of antiinflammatory agents for relief from these symptoms, and the fact that anti-inflammatory agents provide relief from some PMSx, the relationship of inflammation to PMSx has not been well investigated. Methods: We, therefore, undertook the present cross-sectional analyses using baseline data from the longitudinal Study of Women's Health Across the Nation (SWAN), a racially/ethnically diverse cohort of midlife women (n = 2939), to determine if a biomarker of inflammation, high-sensitivity C-reactive protein (hs-CRP), was associated with PMSx. We performed factor analyses with Varimax rotations to determine five groupings of eight symptoms to develop a parsimonious set of outcome variables. We conducted backward stepwise multiple logistic regression models for each grouping, eliminating non-significant ( p > 0.05) covariates. Results: Having an hs-CRP level >3 mg/L was significantly positively associated with premenstrual mood symptoms (adjusted odds ratio [aOR] = 1.27, 95% confidence interval [95% CI] 1.02-1.58), abdominal cramps/ back pain (aOR = 1.40, 95% CI 1.09-1.80), appetite cravings/weight gain/bloating (aOR = 1.41, 95% CI 1.04-1.89), and breast pain (aOR = 1.26, 95% CI 1.02-1.55). Elevated hs-CRP level was not associated with premenstrual headaches or reporting three or more PMSx. Conclusions: The significant relationships of specific groups of PMSx with elevated hs-CRP levels have potential clinical implications for treatment and possibly for prevention by advising women about the factors associated with inflammation and the potential for treatment with anti-inflammatory agents.

show abstract

Section: Unadjusted Analysessupporting

confidence: 87%

Section: Data Analysesmentioning

confidence: 99%

mentioning

confidence: 99%

See 1 more Smart Citation

The Association of Inflammation with Premenstrual Symptoms

Gold

Wells

Rasor

2016

Journal of Women's Health

Self Cite

View full text Add to dashboard Cite

show abstract

“…We selected the following five symptom groupings, based on previously conducted principal components analysis [28]: (1) anxiety/jittery/nervous and mood changes, (2) abdominal cramps and back/joint/muscle pain, (3) increased appetite/craving and weight gain/bloating, (4) breast pain/tenderness, and (5) headaches.…”

Section: Exposure Assessmentmentioning

confidence: 99%

Menstrual and reproductive factors in relation to mammographic density: the Study of Women’s Health Across the Nation (SWAN)

Butler¹,

Gold²,

Greendale

et al. 2007

Breast Cancer Res Treat

Self Cite

View full text Add to dashboard Cite

Menstrual and reproductive factors may increase breast cancer risk through a pathway that includes increased mammographic density. We assessed whether known or suspected menstrual and reproductive breast cancer risk factors were cross-sectionally associated with mammographic density, by measuring area of radiographic density and total breast area on mammograms from 801 participants in the Study of Women's Health Across the Nation (SWAN), a multi-ethnic cohort of pre-and early perimenopausal women. From multivariable linear regression, the following menstrual or reproductive factors were independently associated with percent mammographic density (area of dense breast/breast area): older age at menarche (β = 10.3, P < 0.01, for >13 vs. <12 years), premenstrual cravings and bloating (β = −3.36, P = 0.02), younger age at first full-term birth (β = −8.12, P < 0.01 for ≤23 years versus no births), greater number of births (β = −6.80, P < 0.01 for ≥3 births versus no births), and premenopausal status (β = 3.78, P < 0.01 versus early perimenopausal). Only number of births remained associated with percent density after adjustment for age, race/ ethnicity, study site, body mass index (BMI), and smoking. In addition, stratified analyses revealed that the association with number of births was confined to women within the lowest BMI tertile (β = −12.2, P < 0.01 for ≥3 births versus no births). Our data support a mechanism for parity and breast cancer that involves mammographic density among pre-and early perimenopausal women that may be modified by body size.

show abstract

“…Аналогично, дочери матерей с ПМС имеют на 70% более высокий риск развития ПМС, чем дочери мате-рей без ПМС [13]. Имеются данные о роли конкретных вариантов генов, кодирующих рецепторы серотонина и эстрогенов [32].…”

Section: факторы риска пмдрunclassified

Premenstrual mood disorders: pathogenesis, diagnostic criteria and treatment (a review)

Жиляева¹,

Мазо²

2015

Probl. reprod.

View full text Add to dashboard Cite

Предменструальные расстройства настроения (ПМРН) выявляются у 25% женщин репродуктивного возраста, ухудшают качество жизни пациенток, приводят к сниже-нию трудоспособности: общее бремя этой патологии сопо-ставимо по величине с бременем депрессивных рас-стройств [1]. При этом определения понятий предменстру-ального синдрома (ПМС) и предменструального дисфори-ческого расстройства (ПМДР) длительное время остава-лись фрагментарными; нахождение предмета на стыке ги-некологии и психиатрии приводило к тому, что специали-сты в обеих сферах имели недостаточную настроенность на выявление этих нарушений, и многие пациентки оста-вались без лечения.Первые упоминания о ПМРН можно встретить у Гале-на (II век н.э.), который сообщал о связи болезненного со-стояния женщин накануне циклических кровотечений с фазами Луны [2,3]. В 1931 г. R. Frank (США) [4] впервые описал «синдром предменструального напряжения». Не-смотря на это, в XX веке в большинстве руководств по пси-хиатрии ПМРН упоминались лишь вскользь, и эта тенден-ция сохраняется по сей день. В качестве диагностической единицы они впервые были включены в Диагностическое и статистическое руководство (DSM) версии III-R в 1980 г. как «дисфорическое расстройство поздней лютеиновой e-mail: bizet@inbox.ru Освещены современные представления о расстройствах настроения у женщин, ассоциированных с менструальным циклом: предменструальном синдроме и предменструальном дисфорическом расстройстве. Дано определение этих состояний и представлены критерии их диагностики. Проведен обзор данных, касающихся этиологии и патогенеза, факторов риска, распространенности этих состояний, а также методов их лечения с позиций доказательной медицины. The article provides the current view on mood disorders, associated with the menstrual cycle: premenstrual syndrome (PMS) and premenstrual dysphoric disorder (PMDD). The definition and diagnostic criteria for these conditions are presented. The article includes also literature review concerning etiology, pathogenesis, risk factors, the prevalence of premenstrual syndrome and premenstrual dysphoric disorder, as well as methods of its treatment from the evidence-based medicine point of view.

show abstract

Diet and Lifestyle Factors Associated with Premenstrual Symptoms in a Racially Diverse Community Sample: Study of Women's Health Across the Nation (SWAN)

Cited by 69 publications

References 56 publications

The Association of Inflammation with Premenstrual Symptoms

The Association of Inflammation with Premenstrual Symptoms

Menstrual and reproductive factors in relation to mammographic density: the Study of Women’s Health Across the Nation (SWAN)

Premenstrual mood disorders: pathogenesis, diagnostic criteria and treatment (a review)

Contact Info

Product

Resources

About